[1]
|
Chou Newell, F.W. (1992) Ophtalmology principles and concepts. 7th Edition, Mosby-Year Book, Inc., St. Louis.
|
[2]
|
Winkler, B.S., Boulton, M.E., Gottsch, J.D. and Sternberg, P. (1999) Oxidative damage and age-related macular degeneration. Molecular Vision, 5, 32-37.
|
[3]
|
Tanito, M., Nishiyama, A., Tanaka, T., et al. (2002) Change of redox status and modulation by thiol replenishment in retinal photopxidative damage. Investigative Ophthalmology and Visual Science, 43, 2392-2400.
|
[4]
|
Emirit, J., Edeas, M. and Brikaire, F. (2004) Neurogenerative diseases and oxidative stress. Biomed. Pharmacotherapy, 58, 39-46. doi:10.1016/j.biopha.2003.11.004
|
[5]
|
Roth, F., Bindewald, A., and Holz, F.G. (2004) Key-pathophysiologic pathways in age-related macular disease. Graefe’s Archive for Clinical and Experimental Ophtalmology, 242, 710-716. doi:10.1007/s00417-004-0976-x
|
[6]
|
Tezel, G. (2011) The immune response in glaucoma: A perspective on the roles of oxidative stress. Experimental Eye Research, 93,178-186.
doi:10.1016/j.exer.2010.07.009
|
[7]
|
Antonenko, Y.N., Avetisyan, A.V., Bakeeva, L.E., et al. (2008) Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 1. Cationic plastoquinone derivatives: Synthesis and in vitro studies. Biochemistry, 73, 1273-1287.
doi:10.1134/S0006297908120018
|
[8]
|
Lieberman, E.A., Topali, V.P., Tsofina, L.M., et al. (1969) Mechanism of coupling of oxidative phosphorylation and the membrane potential of mitochondria. Nature, 222, 1076-1078. doi:10.1038/2221076a0
|
[9]
|
Bakeeva, L.E., Barskov, I.V., Egorov, M.V., et al. (2008) Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 2. Treatment of some ROS-and age-related diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke). Biochemistry, 73, 1288-1299. doi:10.1134/S000629790812002X
|
[10]
|
Agapova, L.S., Chernyak, B.V., Domnina, L.V., et al. (2008) Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 3. Inhibitory effect of SkQ1 on tumor development from p53-deficient cells. Biochemistry, 73, 1300-1316.
doi:10.1134/S0006297908120031
|
[11]
|
Neroev, V.V., Archipova, M.M., Bakeeva, L.E., et al. (2008) Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 4. Age-related eye disease. SkQ1 returns vision to blind animals. Biochemistry, 73, 1317-1328.
|
[12]
|
Skulachev, V.P. (2005) How to clean the dirtiest place in the cell: Cationic antioxidants as intramitochondrial ROS scavengers. Life, 57, 305-310.
|
[13]
|
Grigoryan, E.N., Novikova, Y.P., Gancharova, O.S., et al. (2012) New antioxidant SkQ1 is an effective protector of rat eye retinal pigment epithelium and choroids under conditions of long-term organotypic cultivation. Advances in Aging Research, 4, 31-37.
doi:10.4236/aar.2012.12004
|
[14]
|
Grigoryan, E.N., Novikova, Y.P., Kilina, O.V. and Philippov, P.P. (2007) New method of in vitro culturing of pigment retinal epithelium in the structure of the posterior eye sector of adult rat. Bulletin of Experimental Biology and Medicine, 4, 618-625.
doi:10.1007/s10517-007-0389-z
|
[15]
|
Dizhur, A.M., Nekrasova, E.R. and Filippov, P.P. (1991) New 26 kDa protein specific for photoreceptor cells, capable of binding with immobilized delipidized rhodopsin. Biokhimiiya, 56, 225-229.
|
[16]
|
Osborne, N.N. (2008) Pathogenesis of ganglion “cell death” in glaucoma and neuroprotection: Focus on ganglion cell axonal mitochondria. Progress in Brain Research, 173, 339-352.
doi:10.1016/S0079-6123(08)01124-2
|